Literature DB >> 15711227

Community Oriented Program for the Control of Rheumatic Diseases: studies of rheumatic diseases in the developing world.

Kenneth David Muirden1.   

Abstract

PURPOSE OF REVIEW: The Community Orientated Program for the Control of Rheumatic Diseases (COPCORD) is based on collecting community data on rheumatic complaints and disability. After identifying significant problems, a search for disease risk factors is made, and control and treatment measures are recommended. This review covers the results of surveys in five countries-China, Brazil, Kuwait, Vietnam, and Australia-published in the last 18 months. RECENT
FINDINGS: Musculoskeletal pain is a major health problem in all surveys undertaken in both developed and developing countries. Knee and low back pain are the most frequent complaints, and osteoarthritis is the most common arthritic disease identified, particularly affecting the knees. The prevalence of rheumatoid arthritis is generally lesser in these studies compared with published surveys of white patients. However, the prevalence of gout varied widely, possibly because of changes in lifestyle and racial factors. Septic arthritis and rheumatic fever were rarely seen except in an Australian aboriginal community, pointing to improvement in standards of living and health care, at least in the urban settings, according to the Vietnamese authors.
SUMMARY: Population data are required on musculoskeletal complaints as a basis for decisions on health control and treatment programs. Surveys in five countries have identified the frequency of especially knee and low back pain, the prevalence of knee osteoarthritis, and the wide variability in the prevalence of gout, partly because of lifestyle and thus potentially correctable risk factors. Self-medication with potent pharmaceutical products in countries where doctors' prescriptions are not required is a recognizable health hazard.

Entities:  

Mesh:

Year:  2005        PMID: 15711227     DOI: 10.1097/01.bor.0000151402.11028.53

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  11 in total

1.  Impact of musculoskeletal pain on physical function and health-related quality of life in a rural community in south India: a WHO-ILAR-COPCORD-BJD India study.

Authors:  Ashish Jacob Mathew; Arvind Chopra; Dany Varughese Thekkemuriyil; Elizabeth George; Vinay Goyal; Jayakumar Bhaskaran Nair
Journal:  Clin Rheumatol       Date:  2011-08-19       Impact factor: 2.980

2.  Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study.

Authors:  Ysabel Granados; Ligia Cedeño; Celenia Rosillo; Sol Berbin; Miriam Azocar; María Elena Molina; Onelia Lara; Gloris Sanchez; Ingris Peláez-Ballestas
Journal:  Clin Rheumatol       Date:  2014-06-13       Impact factor: 2.980

3.  Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.

Authors:  Rosana Quintana; Mario Goñi; Nora Mathern; Marisa Jorfen; Silvana Conti; Romina Nieto; Alvaro Sanabria; Cristina Prigione; Adriana M R Silvestre; Vanina García; Guillermo Pons-Estel; Ricard Cervera; Conrado García; Ingris Peláez-Ballestas; Graciela S Alarcón; Bernardo A Pons-Estel
Journal:  Clin Rheumatol       Date:  2018-04-19       Impact factor: 2.980

4.  Osteoarthritis of knee joint in metabolic syndrome.

Authors:  Abd El-Moaty Ali Afifi; Reham Magdy Shaat; OLa M Gharbia; Yosra El Boghdadi; Mervat Mohammad El Eshmawy; Ola Ali El-Emam
Journal:  Clin Rheumatol       Date:  2018-07-23       Impact factor: 2.980

5.  Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease.

Authors:  Heng-Jung Hsu; Chiung-Hui Yen; Kuang-Hung Hsu; I-Wen Wu; Chin-Chan Lee; Ming-Jui Hung; Chiao-Yin Sun; Chia-Chi Chou; Yung-Chih Chen; Ming-Fang Hsieh; Chun-Yu Chen; Chiao-Ying Hsu; Chi-Jen Tsai; Mai-Szu Wu
Journal:  BMC Nephrol       Date:  2014-01-08       Impact factor: 2.388

6.  Prevalence of musculoskeletal disorders and rheumatic diseases in the indigenous Qom population of Rosario, Argentina.

Authors:  Rosana Quintana; Adriana M R Silvestre; Mario Goñi; Vanina García; Nora Mathern; Marisa Jorfen; Julio Miljevic; Daniel Dhair; Matias Laithe; Silvana Conti; Fadua Midauar; Maria Celeste Martin; Maria Cecilia Barrios; Romina Nieto; Cristina Prigione; Alvaro Sanabria; Viviana Gervasoni; Emilio Grabbe; Romina Gontero; Ingris Peláez-Ballestas; Bernardo A Pons-Estel
Journal:  Clin Rheumatol       Date:  2016-02-06       Impact factor: 2.980

7.  Prevalence of musculoskeletal disorders and rheumatic disease in the Warao, Kari'ña, and Chaima indigenous populations of Monagas State, Venezuela.

Authors:  Ysabel Granados; Celenia Rosillo; Ligia Cedeño; Yanira Martínez; Gloris Sánchez; Geovalis López; Fernando Pérez; Damarys Martínez; Gabriela Maestre; Sol Berbin; Rosa Chacón; Iván Stekman; Evart Valls; Ingris Peláez-Ballestas
Journal:  Clin Rheumatol       Date:  2016-02-19       Impact factor: 2.980

8.  Prevalence and factors associated with musculoskeletal disorders and rheumatic diseases in indigenous Maya-Yucateco people: a cross-sectional community-based study.

Authors:  I Peláez-Ballestas; J Alvarez-Nemegyei; A Loyola-Sánchez; M L Escudero
Journal:  Clin Rheumatol       Date:  2015-10-05       Impact factor: 2.980

9.  Epidemiology of rheumatic diseases in Mixtec and Chontal indigenous communities in Mexico: a cross-sectional community-based study.

Authors:  Flor Julián-Santiago; Conrado García-García; Imelda García-Olivera; María Victoria Goycochea-Robles; Ingris Pelaez-Ballestas
Journal:  Clin Rheumatol       Date:  2015-12-21       Impact factor: 2.980

10.  Disabling chronic low back pain as an iatrogenic disorder: a qualitative study in Aboriginal Australians.

Authors:  Ivan B Lin; Peter B O'Sullivan; Juli A Coffin; Donna B Mak; Sandy Toussaint; Leon M Straker
Journal:  BMJ Open       Date:  2013-04-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.